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Abstract
OBJECTIVES: We aimed to identify a phenotype of ascending thoracic aortic aneurysm (TAA), which, more than others, evolves into
type A dissection (TAD).
METHODS: Aortic specimens were obtained from patients undergoing surgical repair of TAA and TAD (108 and 26, respectively).
Histopathological and immunohistochemical analyses were performed by using adequate tissue specimens, appropriate techniques and
criteria.
RESULTS: We identiﬁed the three following TAA phenotypes: phenotype I (cystic medial degeneration balanced by a substitutive ﬁbro-
sis, in absence of medial apoptosis and with a faint collagenase concentration), phenotype II (cystic medial degeneration of higher
grade, respectively, than substitutive ﬁbrosis, with focal medial apoptosis and moderate collagenase concentration), and phenotype III
(elevated cystic medial degeneration without substitutive ﬁbrosis, with plurifocal medial apoptosis and severe collagenase concentra-
tion). The same medial degenerative lesions of TAA phenotype III were observed in TAD tissue samples.
CONCLUSIONS: The morphological identity of medial lesions observed in both the TAA phenotype III and in TAD aortas might be assumed to
be the precursor—and consequently the optimal biomarker— of dissection, independently of aneurysm diameter or valvular disorder. Identiﬁcation
of genetic risk factors, useful both in diagnostics and in developing more targeted treatment for individual patients, might also be needed.
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INTRODUCTION
Type A aortic dissection (TAD) represents the most common
aortic emergency. Population-based studies suggest that the inci-
dence of TAD ranges from 2 to 3.5 cases per 100 000 person-
years, with approximately two thirds of dissections involving the
ascending thoracic aorta and one third involving the descending
thoracic aorta [1–4]. It is associated with a mortality rate of up to
80% if left untreated.
Despite the lethality of these disease processes, their under-
lying mechanisms remain poorly understood. It is remarkable
that this condition occurs in aortic walls having both enlarged
aneurysmatic or/and normal diameters.
The medial layer of the aorta is composed of smooth muscle
cells and extracellular matrix proteins, primarily elastin and colla-
gen. Maintaining a balanced composition of vascular smooth
muscle cells and extracellular matrix proteins appears to be critic-
al for preserving the important functional properties of the thor-
acic aorta, especially its mechanical compliance with pulsatile
blood ﬂow. Disturbances in the metabolic balance, resulting in
excessive extracellular matrix degradation, might lead to progres-
sive aortic wall deterioration, expansion, and rupture [5, 6].
This study is a comparative histopathologic study of medial
changes between thoracic ascending aneurysms (TAAs) and TAD.
In particular, our principal aim was to identify a phenotype of
ascending TAAs that was able, more than the others, to evolve in
the dissection complication, independently of aneurysm diam-
eter or valvular disorder.
MATERIALS AND METHODS
Our study received approval from the local ethic committees
and all participants gave their informed consent. Data were
encoded to ensure the anonymity of patients in the study and
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control groups. All measurements were performed without
knowledge of the nature of the study.
Clinical data
Our study included 134 individuals [97 men (72%) and 37 (28%)
women; mean age: 62.95 ± 11.44] from Western Sicily. They were
enrolled from January 2004 to July 2008 at time of their admis-
sion to the cardiac surgery unit of Palermo University Hospital
(Table 1).
Of these patients, 108 (80.6%) were operated on because of
aneurysm and 26 (19%) because of dissection of the ascending
aorta. None were affected by classic Marfan syndrome (accord-
ing to Ghent criteria), nor by Ehler’s Danlos syndrome [4, 7–9]. In
addition, the specimens obtained from thoracic aorta also had
no histological signs of aortitis. This opens up the possibility that
the cases of aneurysm had a dilatative pathology of unknown
etiology and, in some cases, were complicated atherosclerotic
lesions. [10, 11].
For each patient, assessment of the diameter of the ascending
aorta was made both in the operating room and preoperatively,
by transthoracic echocardiography (TTE) and transoesophageal
echocardiography (TEE) and carried out by (i) estimating the
dimensions of the aortic annulus, sinuses of Valsalva and prox-
imal ascending aorta (2.5 cm above the sinotubular junction)
in the parasternal long-axis view and (ii) evaluating the dimen-
sions of the aortic arch from the suprasternal view.
Echocardiography-derived sizes were reported as internal diam-
eter size [12]. Colour Doppler was used to assess the presence
and severity of aortic regurgitation and stenosis. Additionally,
aortic root and ascending aorta diameters were measured using
a helical computed tomography (CT) image analysis technique.
The mean size of photographed aneurysmatic ascending aorta
specimens (see below) after 24 h storage was 53.3 ± 8 (Table 1).
Relevant medical histories of aortic disease were obtained
from patients’ medical records. Thus, demographic and clinical
features, comorbidity conditions and pharmacological treat-
ments were collected. Our patients had commonly suffered from
hypertension for several years. In all cases hypertension was
controlled by beta-blockers (Table 1).
In order to detect histopathological abnormalities, control
ascending aortas were obtained from 30 individuals (20 men
and 10 women; mean age 55 ± 11.57 years), who died from
causes unrelated to aortic disease and no sepsis at the time of
death, as conﬁrmed by autopsy.
Aortic specimens, histopathological assays
Full aortic segments were collected from the resected aortic walls
of 134 patients at the time of surgery and ﬁxed in 10% neutral
buffered formalin for 24 h and then processed for routine parafﬁn
embedding. Surgical specimens were subsequently photographed
and the maximum transverse diameter was measured. Multiple
histological sections from each sample were prepared and stained
with haematoxylin-eosin, Weigert-van Gieson and Alcian-PAS for
microscopic examination. Histopathological abnormalities of
aortic wall media were graded and deﬁned according to the deﬁ-
nitions and grading systems used by Bechtel et al. [13].
Serial sections of these tissues were also used for immuno-
histochemical staining. Aortic wall was mainly evaluated for the
following histological features: fragmentation of elastic and colla-
gen ﬁbre network, presence of necrosis, apoptosis, amounts of
MMP-9, and inﬂammatory cell inﬁltration.
Immunohistochemical assays
Immunohistochemical analyses were performed on 5 µm thick
parafﬁn-embedded sections. The deparafﬁnized sections were
treated for 20 min in a microwave oven in 10 mM citrate buffer
PH6, or TRIS/EDTA PH9. Sections were then incubated for 1 h
with speciﬁc monoclonal antibodies against MMP-9 (Clone
15W2, NCL-MMP9 439 1:50; Novocastra Laboratories Ltd, UK), or
isotype-matched controls at appropriate dilutions. After washing
in TBS 1X (Tris-buffered solution), staining was performed by bio-
tinylated link antibody and peroxidise-labelled streptovidin kits
Table 1: Demographic and clinical characteristics of 134
patients
Variables Patients (n = 134)
Demographic characteristics
Age in years: mean (SD) 62.95 (11.44)
Male sex: no. (%) 97 (72)
Female sex: no. (%) 37 (28)
Body mass index: mean (SD) 27 (4.3)
Size
Size (mm): mean (SD): 53.3 (8)
Location: no. (%)
Ascending aorta 67 (50)
Aortic bulb 15 (11)
Ascending aorta and aortic bulb 52 (39)
Comorbidity conditions: no. (%)
Aortic aneurysm familiarity 7 (5.5)
Cardiovascular ischaemic Familiarity 49 (36.6)
Smoke 60 (45)
Hypertension 106 (78.9)
Dislipidemy 31 (23)
Diabetes mellitus 20 (15)
Renal failure 4 (3.1)
Dissection 26 (19)
Bicuspid aortic valve disease 22 (16.8)
Aortic valve pathology: no. (%)
Normal 75 (56)
Prolapse 17 (13)
Vascular calcium fibrosis 42 (31)
Aortic valve dysfunction: no. (%)
Normal 27 (20)
Faint incontinence 24 (18)
Moderate incontinence 28 (21)
Severe incontinence 37 (28))
Faint stenosis 1 (0.6)
Moderate stenosis 2 (1.2)
Severe stenosis 15 (11.2)
Atherosclerosis coronary syndrome: no. (%) 45 (33.8)
Drugs: no. (%)
Beta-blockers 52 (39)
Central alpha-adrenergic agonists 21 (16)
Sartans 27 (20)
Calcium-channel blockers 39 (29)
ACE inhibitors 55 (41)
Antidiabetic drugs 16 (12)
Anti-aggregant drugs 43 (32)
Anti-dislipidemic drugs 30 (22)
Diuretics 30 (22)
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(Dako North America, Inc, USA) and it was detected using AEC
(3-amino-9-ethylcarbazole) substrate chromogen. After that, the
counterstaining of cells and tissue sections was performed using
aqueous haematoxylin (Novocastra Laboratories Ltd, UK).
TUNEL testing
We performed TdT (terminal deoxynucleotidyl transferase)-
mediated X-dUTP (deoxyuridine triphosphate nucleotides) nick
end-labelling (TUNEL) reaction (In Situ Cell Death Detection kit;
Roche Diagnostics SpA, Milan, Italy) on full-thickness aortic wall
parafﬁn sections (5 µm). Tissues were deparafﬁnized and then
permeabilized with PBS 0.1% sodium citrate/0.1% Triton X-100.
Specimens were then incubated with TdT and ﬂuorescein-
labeled dUTP in a humidiﬁed atmosphere for 1 h at 37°C. In situ
apoptosis staining was revealed by using an AP converter.
DNA strand breaks were detected by using the 5-bromo-4-
chloro-3-indolyl-phosphate (BCIP/NBT; Dako, Italy) substrate
chromogen. Tissues were subsequently counterstained with
eosin under light microscopy.
Semi-quantitative evaluation of MMP-9 by
immunohistochemical assays
A semi-quantitative evaluation of MMP-9 in the aortic specimens
of 134 patients was performed in course of immunohistochemical
assays. Staining was classiﬁed as faint, moderate or severe.
Statistical analysis
All analyses were performed with R (R Foundation) and Excel
(Microsoft) software. Fisher’s test was conducted to compare,
according to gender, all demographic and clinical features, co-
morbidity conditions and pharmacological treatments, and also
to verify the hypothesis of association between elementary
lesions and valvular dysfunction. To verify the hypothesis of a re-
lationship between quantitative variables and histopathological
classiﬁcations, non-parametric Kruskal-Wallis tests were exe-
cuted; this was due to the strong asymmetry of the distributions.
A log-linear (Poisson) model was adapted to analyse the associ-
ation between apoptosis, phlogosis, and collagenases for each
level of histopathological classiﬁcation.
RESULTS
Clinical data
Table 1 reports demographic and clinical features, comorbidity
conditions and pharmacological treatments of all patients.
Histological and immunohistochemical
observations
In the control group, all subjects presented normal aortic wall
without media-degenerative lesions.
Among 108 degenerative TAAs that we studied, 35 (32%) were
atherosclerotic aneurysms (ADAs) and 73 (68%) were non-
atherosclerotic aneurysms (NADAs).
(a) ADAs: histologically, media-degenerative lesions were
present in all cases of ADAs. Table 2 reports the severity of
elastic fragmentation, medionecrosis, cystic necrosis and
medial ﬁbrosis in ADAs. No signiﬁcant associations were
observed between aortic valve dysfunction, with or without
cuspid pathological lesions, or aneurysm diameter and
medial change severity (P-value >0.05 by Fisher’s test; data
not shown). Apoptosis was plurifocal in 16 cases (54%) and
focal in 19 cases (46%). Evaluation of MMP-9 in the aortic
media revealed the absence of these collagenases in 1 case
(3%) and their presence in 34 cases (97%) in differing con-
centrations [faint: 19 cases (54%); moderate: 7 cases (20%);
severe: 8 cases (23%)].
(b) NADAs: histologically, media-degenerative lesions were pre-
sent in all cases of NADAs. Table 2 reports the severity of
elastic fragmentation, medionecrosis, cystic necrosis and
medial ﬁbrosis in NADAs. No signiﬁcant associations were
observed between aortic valve dysfunction, with or without
cuspid pathological lesions, or aneurysm diameter and
medial change severity (P-value >0.05 by Fisher’s test; data
not shown). Apoptosis of media smooth muscle cells was
absent in 5 cases (5%), plurifocal in 55 cases (76%) and focal
in 14 cases (19%). Evaluation of collagenases in aortic media
revealed the presence of MMP-9 in all cases in differing
Table 2: Histological and immunohistochemical observa-
tions in atherosclerotic degenerative aneurysms (ADA),
non-atherosclerotic degenerative aneurysms (NADA) and
thoracic ascending dissections (TAD)
ADA (%)
(n = 35)
NADA (%)
(n = 73)
TAD (%),
(n = 26)
Fibrosis: no. (%)
Absent 4 (11) 16 (22) 8 (24)
Grade I 4 (11) 49 (67) 14 (54)
Grade II 19 (55) 8 (11) 3 (11)
Grade III 8 (23) 0 (0) 3 (11)
Elastic fragmentation: no. (%)
Grade I 18 (51) 17 (21) 3 (11)
Grade II 11 (32) 41 (56) 8 (31)
Grade III 6 (17) 45 (23) 15 (58)
Medionecrosis: no. (%)
Grade I 6 (28) 7 (10) 1 (4)
Grade II 23 (66) 42 (57) 16 (62)
Grade III 6 (6) 24 (33) 9 (34)
Cystic necrosis: no. (%)
Grade I 14 (40) 9 (12) 2 (8)
Grade II 16 (46) 36 (49) 6 (23)
Grade III 5 (14) 28 (39) 18 (69)
Apoptosis: no. (%)
Absent 0 (0) 4 (5) 0 (0)
Focal 19 (54) 14 (19) 7 (27)
Plurifocal 16 (46) 55 (76) 19 (73)
Metalloproteinases: no. (%)
Absent 1 (3) 0 (0) 0 (0)
Faint 19 (54) 5 (7) 3 (12)
Moderate 7 (20) 30 (41) 4 (15)
Severe 8 (23) 38 (52) 19 (73)
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concentrations [faint: 5 cases (7%); moderate: 30 cases (41%);
severe: 38 cases (52%)].
TAD occurred in 26 cases. Table 2 reports the severity of
elastic fragmentation, medionecrosis, cystic necrosis and medial
ﬁbrosis in TAD. Apoptosis was plurifocal in 19 cases (73%) and
focal in 7 cases (27%). Evaluation of MMP-9 in the aortic media
revealed the presence of these collagenases in all cases in differ-
ing concentrations [faint: 3 cases (12%); moderate: 4 cases (15%);
severe: 19 cases (73%)].
Identiﬁcation of three phenotypes in non-
atherosclerotic degenerative aneurysms cases
In the context of NADAs, we identiﬁed three phenotypes charac-
terized by a different quantitative relationship between cystic
medial degeneration, ﬁbrosis and apoptosis:
(i) phenotype I (13 cases): cystic medial degeneration balanced
by a substitutive ﬁbrosis, in absence of medial apoptosis,
and with a faint collagenases concentration.
(ii) phenotype II (22 cases): cystic medial degeneration higher
than substitutive ﬁbrosis, with focal medial apoptosis and
moderate collagenases concentration.
(iii) phenotype III (38 cases): elevated cystic medial degeneration,
without substitutive ﬁbrosis, with plurifocal medial apoptosis
and severe collagenases concentration.
Demographic and clinical features, comorbidity conditions and
pharmacological treatments were compared between the three
NADA phenotypes. No signiﬁcant differences were detected (data
not shown). In contrast, signiﬁcant statistical differences were
observed by comparing abnormalities of extracellular matrix com-
ponents among three NADA phenotypes (ﬁbrosis P < 0.005;
elastic fragmentation P = 0.002; medionecrosis P = 0.004; cystic
necrosis P = 0.07; apoptosis P <0.0001; MMP-9 amount P = 0.004,
by χ2 test and appropriate tables). In particular, NADA phenotype
III was characterized by grade II and III elevated elastic fragmenta-
tion, increased medionecrosis and grade II and III cystic necrosis
(grade III absent in the other two NADA phenotypes), plurifocal
apoptosis, moderate and severe amounts of MMP-9 in respect of
NADA phenotypes I and II. (Table 3 and Fig. 1)
DISCUSSION
Acute ascending aorta dissection is releatively rare compared to
other causes of cardiovascular disease and continues to defy our
attempts to predict or prevent it. Identiﬁcation of patients at risk
for aortic dissection is difﬁcult. Established clinical risk factors are
systemic hypertension (widespread in the general population)
and aortic dilation or aneurysm, which can only be found with
diagnostic imaging. Even patients with Marfan syndrome,
Ehlers-Danlos syndrome, familial aortic aneurysm, or congenital-
ly bicuspid aortic valve, who are known to be at increased risk
for dissection, are frequently unrecognized until an acute aortic
syndrome occurs.
The mainstay of prevention of aortic dissection, aside from
treatment of hypertension, is elective aortic surgery in patients
with dilated ascending aortas. Guidelines for timing of aortic
root repair are based on clinical observations by experienced
clinicians and surgeons, and a consensus based on clinical series
and patient characteristics. Taking into account the consensus,
surgery to prevent rupture or dissection of the ascending thor-
acic aortic aneurysm should be recommended when the ascend-
ing aortic diameter reaches 5.5 cm for non-Marfan patients and
4.5 cm in Marfan patients.
However, many dissection patients do not seem to have
markedly dilated aortas at the time of presentation [14, 15].
In an autopsy study of patients with type A aortic dissection
Neri et al. examined 220 patients, including 94 patients with a
connective tissue disorder including BAV disease (mean aortic
diameter, 41.8 mm), and 126 without a connective tissue dis-
order (mean aortic diameter, 41.3 mm). The authors demon-
strated that aortic dissection occurred in one third of patients
with a normal aortic diameter. Fifty-seven percent of patients
had an aortic diameter >40 mm and only 10% of patients had
a true aneurysm. The authors concluded that dissection,
superimposing on near-normal aortic size, might be an ex-
pression of functional wall changes other than dilatation [16].
Accordingly, in our study, we observed that the severity of
aortic media degeneration in TAD and in TAAs is not related to
the diameter of the aneurysm. We also tested that TAD is often
associated with a non-atherosclerotic pathogenesis. In fact, in
the ADA aortas, the grade of medial degenerative lesions
Table 3: Histological and immunohistochemical observa-
tions in non-atherosclerotic degenerative aneurysms
phenotype I (NADA I), non-atherosclerotic degenerative
aneurysms phenotype II (NADA II) and non-atherosclerotic
degenerative aneurysms phenotype III (NADA III)
Patients (n
= 73)
NADAI-II (n
= 9)
NADAIII (n
= 64)
P-value
Fibrosis: no.
(%)
0.005
Absent 17 (23) 0 (0) 17 (27)
Grade I 50 (69) 6 (67) 44 (69)
Grade II 6 (8) 3 (33) 3 (4)
Grade III 0 (0) 0 (0) 0 (0)
Elastic fragmentation: no. (%) 0.002
Grade I 15 (21) 5 (56) 10 (16)
Grade II 39 (53) 4 (44) 35 (54)
Grade III 19 (26) 0 (0) 19 (30)
Medionecrosis: no. (%) 0.004
Grade I 7 (10) 0 (0) 7 (11)
Grade II 38 (52) 9 (100) 29 (45)
Grade III 28 (38) 0 (0) 28 (44)
Cystic necrosis: no. (%) 0.07
Grade I 4 (6) 1 (11) 3 (4)
Grade II 37 (51) 7 (78) 30 (47)
Grade III 32 (43) 1 (11) 31 (49)
Apoptosis: no.
(%)
<0.0001
Absent 2 (3) 2 (22) 0 (0)
Focal 15 (21) 6 (67) 9 (14)
Plurifocal 56 (76) 1 (11) 55 (86)
Metalloproteinases: no. (%) 0.004
Absent 0 (0) 0 (0) 0 (0)
Faint 4 (6) 2 (22) 2 (3)
Moderate 24 (33) 6 (67) 18 (28)
Severe 45 (61) 1 (11) 44 (69)
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was balanced to the grade of substitutive medial ﬁbrosis. In
contrast, in NADA and TAD, medial ﬁbrosis was absent or of
grade I (Figs. 2 and 3).
The relative absence of reparative ﬁbrosis should predispose
patients to aortic rupture. In particular, our study showed that
TAD has the same histological and immunohistochemical fea-
tures as phenotype III of NADA: elevated cystic medial degener-
ation, without substitutive ﬁbrosis, with plurifocal medial
apoptosis and severe collagenases concentration. Our results
agree with recent studies that showed that an up-regulation of
metalloproteinases, related to inﬂammatory processes or genetic
aspects, might affect the formation of TAA and TADs. Jones et al.
demonstrated that the loss of speciﬁc micro-RNA expression
may allow for the elaboration of MMPs capable of driving aortic
remodelling during TAA development [17]. Zhang et al. con-
cluded that interleukin-1β and interferon-γ might cause the for-
mation of TAD and TAA, possibly through the up-regulation of
matrix metalloproteinase-9 and the apoptosis of media cells in
humans [18]. Levula et al. concluded that the involvement of
MMP-8 and MMP-15, together with inﬂammation consisting of
B-cells may indicate active remodelling of the aortic wall,
leading to TAD [19].
Figure 1: Histological and immunohistochemical observations in non-atherosclerotic degenerative aneurysms: phenotype I (NADA I); phenotype II (NADA II); pheno-
type III (NADA III).
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In contrast with the data showed by Robert et al., our study
conﬁrmed that, in most cases of TAD, elastic fragmentation was
moderate and severe [20]. The loss of elastic ﬁbre integrity might
be one of the most important elements that affects smooth
muscle cells apoptosis.
CONCLUSION
The morphological identity of medial lesions observed in the pheno-
type III of NADA and in the aortic dissection leads us to suppose
that this phenotype might represent the precursor of dissection, in-
dependently of aneurysm diameter and/or valvular dysfunction.
Finally, the high quantity of metalloproteinases in NADA phenotype
III, without phlogosis reaction, suggests that research into a particular
genetic polymorphism be carried out on these patients and their
families.
Study limitations
The principle limitation of this study is the limited sample size
and the rarity of BAV pathology. Also, surgical recommendations
require genetic and clinical data as main support.
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Figure 2: Histological observations on thoracic ascending dissection.
Figure 3: Immunohistochemical observations on thoracic ascending dissection.
O
R
IG
IN
A
L
A
R
TI
C
LE
C. Pisano et al. / Interactive CardioVascular and Thoracic Surgery 845
ACKNOWLEDGMENTS
The authors gratefully acknowledge Federico Torretta, who is a
doctor of statistics and who contributed to the statistical analysis
of the study data.
Conﬂict of interest: none declared.
REFERENCES
[1] ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM. Guidelines for the
Diagnosis and Management of Patients with Thoracic Aortic Disease.
Circulation 2010;121:e266–e369.
[2] Neuhauser B, Greiner A, Jaschke W, Chemelli A, Fraedrich G. Serious
complications following endovascular thoracic aortic stent-graft repair
for type B dissection. Eur J Cardiothorac Surg 2008;33:58–63.
[3] Nathan DP, Xu C, Gorman JH 3rd, Fairman RM, Bavaria JE, Gorman RC,
Chandran KB, Jackson BM. Pathogenesis of acute aortic dissection: a
ﬁnite element stress analysis. Ann Thorac Surg 2011;91:458–63.
[4] Mehta RH, Suzuki T, Hagan PG, Bossone E, Gilon D, Llovet A, Maroto LC,
Cooper JV, Smith DE, Armstrong WF, Nienaber CA, Eagle KA;
International Registry of Acute Aortic Dissection (IRAD) Investigators.
Predicting death in patients with acute type a aortic dissection.
Circulation. 2005;105:200–6.
[5] Zhang L, Liao MF, Tian L, Zou SL, Lu QS, Bao JM, Pei YF, Jing ZP.
Overexpression of interleukin-1b and interferon-g in type I thoracic
aortic dissections and ascending thoracic aortic aneurysms: possible cor-
relation with matrix metalloproteinase-9 expression and apoptosis of
aortic media cells. Eur J Cardiothorac Surg 2011;40:17–22.
[6] Golledge J, Eagle KA. Acute aortic dissection. Lancet. 2008;372:55–66.
[7] De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised
diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996;62:
417–26.
[8] Parapia LA, Jackson C. Ehlers-Danlos syndrome-a historical review. Br J
Haematol 2008;141:32–5.
[9] Callewaert B, Malfait F, Loeys B, De Paepe A. Ehlers-Danlos syndromes
and Marfan syndrome. Best Pract Res Clin Rheumatol 2008;22:165–89.
[10] Virmani R, Burke AP. Nonatherosclerotic diseases of the aorta and
miscellaneous diseases of the main pulmonary arteries and large veins.
In: Silver MD, Gotlieb AI, Schoen FJ (eds). Cardiovascular pathology, 3rd
edn. New York: Churchill Livingstone, 2001, 107–37.
[11] Schmoker Joseph D, McPartland Kenneth J, Howard Alan. Matrix metal-
loproteinase and tissue inhibitor expression in atherosclerotic and non-
atherosclerotic thoracic aortic aneurysms. J Thorac CardioVasc Surg
2007;133:155–61.
[12] Evangelista A, Flachskampt FA, Erbe R, Antonini-Canterin F,
Vlachopoulos C, Rocchi G, Sicari R, Nihoyannopoulos P, Zamorano J.
Echocardiography in aortic diseases: EAE recommendations for clinical
practice. Eur J Echocardiogr 2010;11:645–58.
[13] Bechtel JF, Noack F, Sayk F, Erasmi AW, Bartels C, Sievers HH.
Histopathological Grading of Ascending Aortic Aneurysm: Comparison
of Patients with Bicuspid versus Tricuspid Aortic Valve. J Heart Valve Dis
2003;12:54–61.
[14] Parish LM, Gorman JH 3rd, Kahn S, Plappert T, St John-Sutton MG,
Bavaria JE, Gorman RC. Aortic size in acute type A dissection: implica-
tions for preventive ascending aortic replacement. Eur J Cardiothorac
Surg 2009;35:941–5.
[15] Nathan DP, Xu C, Gorman JH 3rd, Fairman RM, Bavaria JE, Gorman RC,
Chandran KB, Jackson BM. Pathogenesis of acute aortic dissection: a
ﬁnite element stress analysis. Ann Thorac Surg 2011;91:458–63.
[16] Neri E, Barabesi L, Buklas D, Vricella LA, Benvenuti A, Tucci E, Sassi C,
Massetti M. Limited role of aortic size in the genesis of acute type A
aortic dissection. Eur J Cardiothorac Surg 2005;28:857–63.
[17] Jones JA, Stroud RE, O’Quinn EC, Black LE, Barth JL, Elefteriades JA,
Bavaria JE, Gorman JH 3rd, Gorman RC, Spinale FG, Ikonomidis JS.
Selective microRNA suppression in human thoracic aneurysms: relation-
ship of miR-29a to aortic size and proteolytic induction. Circ Cardiovasc
Genet 2011;4:605–13.
[18] Zhang L, Liao MF, Tian L, Zou SL, Lu QS, Bao JM, Pei YF, Jing ZP.
Overexpression of interleukin-1β and interferon-γ in type I thor-
acic aortic dissections and ascending thoracic aortic aneurysms:
possible correlation with matrix metalloproteinase-9 expression
and apoptosis of aortic media cells. Eur J Cardiothorac Surg 2011;
40:17–22.
[19] Levula M, Paavonen T, Valo T, Pelto-Huikko M, Laaksonen R, Kahonen
M, Huovila A, Lehtimaki T, Tarkka M, Mennander AA. A disintegrin and
metalloprotease -8 and -15 and susceptibility for ascending aortic dis-
section. Scand J Clin Lab Invest 2011;71:515–22.
[20] Roberts WC, Vowels TJ, Kitchens BL, Ko JM, Filardo G, Henry AC,
Hamman BL, Matter GJ, Hebeler RF Jr. Aortic medial elastic ﬁber loss
in acute ascending aortic dissection. Am J Cardiol 2011;108:1639–44.
C. Pisano et al. / Interactive CardioVascular and Thoracic Surgery846
